The startups winning in patient access right now are not pitching patients anymore. They are pitching the employers and health plans that decide what patients can access in the first place.
A consumer facing access tool has to convince one patient at a time that it is worth using, which is a slow, expensive way to grow. A benefits infrastructure model gets adopted once, at the employer or plan level, and then reaches every covered member automatically, without needing to individually win each person's attention.
A shift from patient tool to institutional infrastructure
A shift is underway among patient access and affordability startups, away from consumer facing tools that help individuals navigate their own coverage, and toward becoming embedded infrastructure inside employer benefits packages and health plan networks themselves. That shift mirrors the same institutional distribution logic showing up in the prevention startups covered earlier in this issue, selling to the institution controlling coverage, not the individual trying to use it.
This mirrors a pattern showing up across several categories in digital health this year, point solutions that once sold directly to individual patients are repositioning as infrastructure that sells to the institutions controlling coverage decisions instead. The economics of institutional distribution are simply better than the economics of one patient at a time adoption, and enough startups have made this pivot now that it looks like a category-wide trend rather than a handful of isolated strategic decisions.
Benefits design, not patient education, is the real lever
The startups that figured out access is fundamentally a benefits design problem, not a patient education problem, are the ones scaling fastest in this category right now, a distinction that changes who the actual buyer needs to be.
That reframing has real implications for how these companies sell. A patient education pitch requires convincing individuals, one at a time, that a tool is worth their attention. A benefits design pitch requires convincing a much smaller number of institutional buyers, employers and health plans, that the infrastructure is worth embedding permanently into how coverage works. The second sale is harder to close but far more durable once it lands.
Dependency risk versus diversified growth
The risk in this model is dependency. A startup that becomes deeply embedded in one health plan's infrastructure is exposed if that plan changes vendors or brings the capability in house, a risk that does not exist in the same way for a consumer facing product with a broad, diversified user base.
Watch which of these companies are diversifying across multiple employer and plan relationships early, versus concentrating around one large anchor partner, since that decision will determine how resilient the category's leaders actually are once the current funding cycle cools and institutional buyers start negotiating harder on renewal terms.
